Colgate EVP Gregory sells 12,747 shares after option exercise

Colgate-Palmolive executive Malcolm Gregory reported an employee stock option exercise and related share sale.

Rhea-AI Filing Summary

Colgate-Palmolive executive Malcolm Gregory reported an employee stock option exercise and related share sale. On February 6, 2026, he exercised options for 12,747 shares of common stock at $76.41 per share under the company’s incentive compensation plan.

That same day, he sold 12,747 shares of Colgate-Palmolive common stock in market transactions at a weighted average price of $94.9103 per share, with individual trades ranging from $94.79 to $95.01. After these transactions, he directly owned 11,879 shares and held an additional 8,554 shares indirectly through the issuer’s 401(k) plan trustee.

Insider Trade Summary

Exercise and Sale: 12,747 shares ($236K approx. pre-tax spread)

Exercise and Sale 4 txns

Insider Malcolm Gregory

Role EVP and Controller

Sold 12,747 shs ($1.21M)

Approx. gross sale proceeds $1.21M

Approx. exercise cost $974K

Approx. pre-tax spread $236K

Type	Security	Shares	Price	Value
Exercise	Stock Option (Right to Buy)	12,747	$0.00	$0.00
Exercise	Common Stock	12,747	$76.41	$974K
Sale	Common Stock	12,747	$94.9103	$1.21M
holding	Common Stock	--	--	--

Holdings After Transaction: Stock Option (Right to Buy) — 0 contracts (Direct); Common Stock — 11,879 shares (Direct); Common Stock — 8,554 shares (Indirect, By Issuer's 401(k) Plan Trustee)

Footnotes (4)

1. F1. Exercise of stock options awarded under the issuer's incentive compensation plan.
2. F2. Sale of shares with a portion of the proceeds delivered to the issuer for payment of the exercise price of options under the issuer's incentive compensation plan and the related tax withholding.
3. F3. Weighted average price, as these shares were sold in multiple transactions at prices ranging from $94.79 to $95.01 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote.
4. F4. Option became exercisable in one-third increments beginning on the first anniversary of the September 10, 2020 grant date.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Colgate-Palmolive (CL) executive Malcolm Gregory report?

Malcolm Gregory reported exercising stock options for 12,747 Colgate-Palmolive common shares and selling 12,747 shares the same day. These transactions were made under the company’s incentive compensation plan and disclosed in a Form 4 insider filing.

How many Colgate-Palmolive (CL) shares did Malcolm Gregory sell and at what price?

Malcolm Gregory sold 12,747 Colgate-Palmolive common shares at a weighted average price of $94.9103 per share. The trades occurred in multiple transactions within a price range from $94.79 to $95.01 inclusive, as disclosed in the filing footnotes.

What stock options did Malcolm Gregory exercise at Colgate-Palmolive (CL)?

He exercised a stock option for 12,747 Colgate-Palmolive common shares at an exercise price of $76.41 per share. The option became exercisable in one-third increments starting on the first anniversary of the September 10, 2020 grant date, under the incentive plan.

How many Colgate-Palmolive (CL) shares does Malcolm Gregory own after the reported transactions?

After the reported transactions, Malcolm Gregory directly owned 11,879 Colgate-Palmolive common shares. He also held 8,554 additional shares indirectly through the issuer’s 401(k) plan trustee, as shown in the beneficial ownership table of the Form 4 filing.

What role does Malcolm Gregory hold at Colgate-Palmolive (CL)?

Malcolm Gregory is an officer of Colgate-Palmolive, serving as Executive Vice President (EVP) and Controller. He is not listed as a director or 10% owner, and the Form 4 reflects transactions related to his executive compensation awards.

How were the proceeds of Malcolm Gregory’s Colgate-Palmolive (CL) share sale used?

A portion of the proceeds from Malcolm Gregory’s sale of Colgate-Palmolive shares was delivered to the issuer. These funds were used to pay the option exercise price under the incentive compensation plan and to satisfy related tax withholding obligations, according to the footnotes.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/10/2026 - 04:21 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Malcolm Gregory

(Last) (First) (Middle)

C/O COLGATE-PALMOLIVE COMPANY

300 PARK AVENUE

(Street)

NEW YORK NY 10022

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
COLGATE PALMOLIVE CO [ CL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP and Controller

3. Date of Earliest Transaction (Month/Day/Year)
02/06/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/06/2026		M(1)		12,747	A	$76.41	24,626	D
Common Stock	02/06/2026		S(2)		12,747	D	$94.9103(3)	11,879	D
Common Stock								8,554	I	By Issuer's 401(k) Plan Trustee

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$76.41	02/06/2026		M(1)			12,747	(4)	09/10/2028	Common Stock	12,747	$0.0000	0.0000	D

Explanation of Responses:

1. Exercise of stock options awarded under the issuer's incentive compensation plan.

2. Sale of shares with a portion of the proceeds delivered to the issuer for payment of the exercise price of options under the issuer's incentive compensation plan and the related tax withholding.

3. Weighted average price, as these shares were sold in multiple transactions at prices ranging from $94.79 to $95.01 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote.

4. Option became exercisable in one-third increments beginning on the first anniversary of the September 10, 2020 grant date.

	/s/ Kristine Hutchinson, Attorney-in-Fact	02/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.